相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。VEGF regulates local inhibitory complement proteins in the eye and kidney
Lindsay S. Keir et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
Qunling Zhang et al.
ONCOTARGETS AND THERAPY (2017)
Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease
Annelie Falkevall et al.
CELL METABOLISM (2017)
Expression of vascular endothelial growth factor (VEGF)-B and its receptor (VEGFR1) in murine heart, lung and kidney
Lars Muhl et al.
CELL AND TISSUE RESEARCH (2016)
The association between endostatin and kidney disease and mortality in patients with type 2 diabetes
A. C. Carlsson et al.
DIABETES & METABOLISM (2016)
Serum and Plasma Levels of Vascular Endothelial Growth Factors in Relation to Quality of Glucose Control, Biomarkers of Inflammation, and Diabetic Nephropathy
M. Hanefeld et al.
HORMONE AND METABOLIC RESEARCH (2016)
Levels of Serum 25(OH)VD3, HIF-1 alpha, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio
Ying Shao et al.
JOURNAL OF DIABETES RESEARCH (2016)
The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival
Yoshifumi Takahashi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Novel Link between Inhibition of Angiogenesis and Tolerance to Vascular Stress
Yasufumi Sato
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
Vascular Endothelial Growth Factor-A(165)b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy
Sebastian Oltean et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer
Jaime Feliu et al.
PLOS ONE (2015)
Incidence and Relevance of Proteinuria in Bevacizumab-Treated Patients: Pooled Analysis from Randomized Controlled Trials
Richard A. Lafayette et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma
Keigo Murakami et al.
HUMAN PATHOLOGY (2014)
Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease
Cecile Dessapt-Baradez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Podocyte-Specific VEGF-A Gain of Function Induces Nodular Glomerulosclerosis in eNOS Null Mice
Delma Veron et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Urinary and Plasma Levels of Vasohibin-1 Can Predict Renal Functional Deterioration in Patients with Renal Disorders
Norikazu Hinamoto et al.
PLOS ONE (2014)
Vascular Endothelial Growth Factor-Receptor 1 Inhibition Aggravates Diabetic Nephropathy through eNOS Signaling Pathway in db/db Mice
Keun Suk Yang et al.
PLOS ONE (2014)
Exacerbation of Diabetic Renal Alterations in Mice Lacking Vasohibin-1
Norikazu Hinamoto et al.
PLOS ONE (2014)
Vasohibin-1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstruction
Hiroyuki Watatani et al.
PHYSIOLOGICAL REPORTS (2014)
Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study
Jianghao Chen et al.
BMC CANCER (2013)
The prognostic significance of vasohibin-1 expression in patients with prostate cancer
T. Kosaka et al.
BRITISH JOURNAL OF CANCER (2013)
Transscleral Sustained Vasohibin-1 Delivery by a Novel Device Suppressed Experimentally-Induced Choroidal Neovascularization
Hideyuki Onami et al.
PLOS ONE (2013)
Uncoupling of VEGF with Endothelial NO as a Potential Mechanism for Abnormal Angiogenesis in the Diabetic Nephropathy
Takahiko Nakagawa et al.
JOURNAL OF DIABETES RESEARCH (2013)
The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma
Yasumasa Miyazaki et al.
CLINICAL CANCER RESEARCH (2012)
Vegfa Protects the Glomerular Microvasculature in Diabetes
Gavasker A. Sivaskandarajah et al.
DIABETES (2012)
Vasohibin induces prolyl hydroxylase-mediated degradation of hypoxia-inducible factor-1α in human umbilical vein endothelial cells
Tomohiro Kozako et al.
FEBS LETTERS (2012)
eNOS Deficiency Predisposes Podocytes to Injury in Diabetes
Darren A. Yuen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Angiogenesis Inhibitor Vasohibin-1 Enhances Stress Resistance of Endothelial Cells via Induction of SOD2 and SIRT1
Hiroki Miyashita et al.
PLOS ONE (2012)
A Potent Anti-angiogenic Factor, Vasohibin-1, Ameliorates Experimental Bronchiolitis Obliterans
T. Watanabe et al.
TRANSPLANTATION PROCEEDINGS (2012)
Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse
Katsuyuki Tanabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Selective Stimulation of VEGFR2 Accelerates Progressive Renal Disease
Waichi Sato et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Podocyte vascular endothelial growth factor (Vegf 164 ) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes
D. Veron et al.
DIABETOLOGIA (2011)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer
Baohui Han et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions
Nadejda Vintonenko et al.
CELL ADHESION & MIGRATION (2011)
Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis
Daisuke Saito et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Suppression of the Nitric Oxide Pathway in Metastatic Renal Cell Carcinoma Patients Receiving Vascular Endothelial Growth Factor-Signaling Inhibitors
Emily S. Robinson et al.
HYPERTENSION (2010)
Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion
Yasuhiro Suzuki et al.
JOURNAL OF CELL SCIENCE (2010)
Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model
Astrid Bergmann et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Overexpression of VEGF165b in Podocytes Reduces Glomerular Permeability
Yan Qiu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease
Delma Veron et al.
KIDNEY INTERNATIONAL (2010)
VEGF-A165b Is Cytoprotective and Antiangiogenic in the Retina
Anette L. Magnussen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice
Tomoki Kosugi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Vasohibin-1 Expression in Endothelium of Tumor Blood Vessels Regulates Angiogenesis
Tomoko Hosaka et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Vasohibin-1, a Negative Feedback Regulator of Angiogenesis, Ameliorates Renal Alterations in a Mouse Model of Diabetic Nephropathy
Tatsuyo Nasu et al.
DIABETES (2009)
Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism
Wei Mu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity
Harukiyo Kawamura et al.
CANCER RESEARCH (2008)
Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice
Ching-Hsin Ku et al.
DIABETES (2008)
A Preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib
Tejas V. Patel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The Alternatively Spliced Anti-Angiogenic Family of VEGF Isoforms VEGF(xxx)b in Human Kidney Development
Heather S. Bevan et al.
NEPHRON PHYSIOLOGY (2008)
VEGF Inhibition and Renal Thrombotic Microangiopathy
NEW ENGLAND JOURNAL OF MEDICINE (2008)
VEGF inhibition and renal thrombotic microangiopathy
Vera Eremina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Modification of kidney barrier function by the urokinase receptor
Changli Wei et al.
NATURE MEDICINE (2008)
Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting
Qi Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions
Enqi Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease
Takahiko Nakagawa
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: Systematic review and meta-analysis
Xiaolei Zhu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model
K. Tanabe et al.
KIDNEY INTERNATIONAL (2007)
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy
Takahiko Nakagawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice
Sun Hee Sung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice
Hui John Zhao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2
S. Cebe Suarez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Vasohibin prevents arterial neointimal formation through angiogenesis inhibition
Hiroshi Yamashita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man
B Hohenstein et al.
KIDNEY INTERNATIONAL (2006)
Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin
H Sonoda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Therapeutic potential of angiostatin in diabetic nephropathy
Sarah X. Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy
M Guo et al.
JOURNAL OF ANATOMY (2005)
Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model
K Ichinose et al.
DIABETES (2005)
Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy
Y Kanesaki et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
NH Kim et al.
KIDNEY INTERNATIONAL (2005)
Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy
HJ Baelde et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy
Y Yamamoto et al.
DIABETES (2004)
Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis
A Shimizu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin
Y Hamano et al.
CANCER CELL (2003)
Human tumstatin land human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins
A Sudhakar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria
H Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
V Eremina et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody
A Flyvbjerg et al.
DIABETES (2002)
Tumstatin, an endothelial cell-specific inhibitor of protein synthesis
Y Maeshima et al.
SCIENCE (2002)
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-γ and DNA synthesis in vascular endothelial cells
T Takahashi et al.
EMBO JOURNAL (2001)
On glomerular structural alterations in type-1 diabetes - Companions of early diabetic glomerulopathy
R Osterby et al.
VIRCHOWS ARCHIV (2001)
Role of vascular endothelial growth factor in diabetic nephropathy
DR Cha et al.
KIDNEY INTERNATIONAL (2000)
Distinct antitumor properties of a type IV collagen domain derived from basement membrane
Y Maeshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy
P Hovind et al.
KIDNEY INTERNATIONAL (2000)
分享论文
